title: Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population.
abstract: Congenital Dyserythropoietic Anemia type II is an autosomal recessive disorder characterized by unique abnormalities in the differentiation of cells of the erythroid lineage. The vast majority of CDA II cases result from mutations in the SEC23B gene. To date, 53 different causative mutations have been reported in 86 unrelated cases (from the CDA II European Registry), 47 of them Italian. We have now identified SEC23B mutations in 23 additional patients, 17 Italians and 6 non-Italian Europeans. The relative allelic frequency of the mutations was then reassessed in a total of 64 Italian and 45 non-Italian unrelated patients. Two mutations, E109K and R14W, account for over one-half of the cases of CDA II in Italy. Whereas the relative frequency of E109K is similar in Italy and in the rest of Europe (and is also prevalent in Moroccan Jews), the relative frequency of R14W is significantly higher in Italy (26.3% vs. 10.7%). By haplotype analysis we demonstrated that both are founder mutations in the Italian population. By using the DMLE+ program our estimate for the age of the E109K mutation in Italian population is ≈2,200 years; whereas for the R14W mutation it is ≈3,000 years. We hypothesize that E109K may have originated in the Middle East and may have spread in the heyday of the Roman Empire. Instead, R14W may have originated in Southern Italy. The relatively high frequency of the R14W mutation may account for the known increased prevalence of CDA II in Italy.
authors.affiliation: CEINGE Biotecnologie Avanzate, Napoli, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Russo
authors.forename: Antonella
authors.initials: A
authors.lastname: Gambale
authors.forename: Maria Rosaria
authors.initials: MR
authors.lastname: Esposito
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Serra
authors.forename: Annaelena
authors.initials: A
authors.lastname: Troiano
authors.forename: Ilaria
authors.initials: I
authors.lastname: De Maggio
authors.forename: Mario
authors.initials: M
authors.lastname: Capasso
authors.forename: Lucio
authors.initials: L
authors.lastname: Luzzatto
authors.forename: Jean
authors.initials: J
authors.lastname: Delaunay
authors.forename: Hannah
authors.initials: H
authors.lastname: Tamary
authors.forename: Achille
authors.initials: A
authors.lastname: Iolascon
mesh_terms: D019943:Amino Acid Substitution; D000742:Anemia, Dyserythropoietic, Congenital / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D004252:DNA Mutational Analysis; D005060:Europe / Q000453:epidemiology; D019143:Evolution, Molecular; D005260:Female; D018703:Founder Effect; D005787:Gene Frequency; D056726:Genetic Association Studies; D006239:Haplotypes; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D019083:Mediterranean Region / Q000453:epidemiology; D009154:Mutation; D020641:Polymorphism, Single Nucleotide; D015995:Prevalence; D012042:Registries; D033921:Vesicular Transport Proteins / Q000235:genetics*
chemical_list: C543353:SEC23B protein, human; D033921:Vesicular Transport Proteins